Related Experiment Video
Updated: May 30, 2025

Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
A role for mitochondria-ER crosstalk in amyotrophic lateral sclerosis 8 pathogenesis
Cathal Wilson1,2, Laura Giaquinto3,2, Michele Santoro3
1Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Italy cathalwilson636@gmail.com.
Abstract:
Protein aggregates in motoneurons, a pathological hallmark of amyotrophic lateral sclerosis, have been suggested to play a key pathogenetic role. ALS8, characterized by ER-associated inclusions, is caused by a heterozygous mutation in VAPB, which acts at multiple membrane contact sites between the ER and almost all other organelles. The link between protein aggregation and cellular dysfunction is unclear. A yeast model, expressing human mutant and WT-VAPB under the control of the orthologous yeast promoter in haploid and diploid cells, was developed to mimic the disease situation. Inclusion formation was found to be a developmentally regulated process linked to mitochondrial damage that could be attenuated by reducing ER-mitochondrial contacts. The co-expression of the WT protein retarded P56S-VAPB inclusion formation. Importantly, we validated these results in mammalian motoneuron cells. Our findings indicate that (age-related) damage to mitochondria influences the propensity of the mutant VAPB to form aggregates via ER-mitochondrial contacts, initiating a series of events leading to disease progression.
Insights
Amyotrophic lateral sclerosis (ALS) protein aggregates form due to mitochondrial damage influencing VAPB mutations. Reducing ER-mitochondrial contacts can attenuate this, offering a potential therapeutic target for ALS.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Protein aggregates in motoneurons are a hallmark of amyotrophic lateral sclerosis (ALS).
- ALS8 is linked to VAPB mutations, affecting endoplasmic reticulum (ER) and organelle contacts.
- The connection between protein aggregation and cellular dysfunction in ALS remains unclear.
Purpose of the Study:
- To investigate the role of VAPB mutations in protein aggregation and cellular dysfunction in ALS.
- To explore the link between ER-mitochondrial contacts and aggregate formation.
- To identify potential therapeutic strategies by modulating these cellular processes.
Main Methods:
- Developed a yeast model expressing human mutant and wild-type (WT) VAPB.
- Analyzed inclusion formation and its link to mitochondrial damage.
- Investigated the effect of reducing ER-mitochondrial contacts.
- Validated findings in mammalian motoneuron cells.
Main Results:
- Inclusion formation is developmentally regulated and linked to mitochondrial damage.
- Reducing ER-mitochondrial contacts attenuated aggregate formation.
- Co-expression of WT VAPB slowed mutant protein aggregation.
- Results were confirmed in mammalian motoneuron models.
Conclusions:
- Mitochondrial damage influences mutant VAPB aggregation via ER-mitochondrial contacts in ALS.
- This process initiates a cascade leading to disease progression.
- Modulating ER-mitochondrial contacts may offer a therapeutic avenue for ALS.
Related Concept Videos
Mitochondria
Cross-bridge Cycle
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondrial Membranes
Lysosomal Hydrolases

